猪伪狂犬病毒gB基因序列分析

2011年以来我国多省免疫猪伪狂犬病毒gE基因缺失苗猪场出现变异型猪伪狂犬病毒(PRV)感染,经典猪伪狂犬病毒疫苗(Bartha-k61)对该病无法提供100%有效保护,已有研究发现变异型PRV和经典PRV gE基因存在特征性变异。为明确变异型PRVgB基因特征,本研究对GenBank中登录的部分PRV代表株gB基因进行分析比较。结果表明,我国经典型和变异型PRV在gB蛋白氨基酸编码区第395位、453位、562位和739位存在特征性差异,但不同来源PRVgB基因的核苷酸和氨基酸同源性分别在98.1%~100%和96.1%~100%。从相互之间的遗传进化关系可以看出,PRV遗传进化出现两个大的遗传分支,呈现明显的地域性。新发变异型和经典型PRV在中国PRV遗传进化分支上呈现各自独立进化小分支;我国近年分离的貉源和约克夏梗犬源与新发变异型PRV则处于同一进化小分支。     

Bioinformatics Analysis of gB Gene of Porcine Lymphotropic Herpesviruses Strain GD27

The glycoproteins B (gB) gene of porcine lymphotropic herpesviruses 2 (PLHV-2)was amplified by PCR and sequenced, then bioinformatics analysis were conducted. The gB protein was composed of 876 amino acids, the molecular formula was C₄₅₀₀H₆₉₇₅N₁₁₉₉O₁₃₅₁S₄₀, the molecular mass was 100.77 ku, the value of theoretical isoelectric point was 6.45, and the instability index was 38.58. The prediction of secondary structure revealed that some alpha helixes and beta sheets exist in protein while random coil was major pattern. It had a signal peptide in the position 1-39 amino acids and a transmembrane helice in the position 761-780 amino acids. It contained several prosites and several intrinsically disordered proteins. Tertiary structure model of gB protein showed a fusion loop. Multiple antigenic epitope located in gB through comprehensive analysis prediction method. It was suggested that gB gene could be as a candidate antigen for vaccination of PLHV-2.     

牛疱疹病毒I型gB基因原核表达载体的构建和高效表达

用PCR法扩增了牛疱疹病毒Ⅰ型B artha N u/67株gB基因,将其插入原核表达载体pBAD/TOPO中构建重组质粒pBAD-gB。将pBAD-gB质粒转化大肠杆菌TOP 10后进行了诱导表达,对表达产物进行了纯化和抗原性检测,并通过改变诱导剂L-A rab inose的浓度和诱导时间对诱导表达条件进行了优化。结果表明,重组质粒pBAD-gB构建成功,gB蛋白获得了高效表达,并以包涵体形式存在,纯化后gB蛋白的纯度达90%以上,gB蛋白抗原性良好,最佳诱导表达条件:L-A rab inose终浓度为0.2 g/L,诱导时间为5 h。     

猪伪狂犬病病毒gB蛋白抗体竞争化学发光酶联免疫检测方法的建立

为了建立一种快速定量检测猪伪狂犬病病毒（PRV）gB蛋白抗体的竞争化学发光酶联免疫检测方法,以大肠杆菌表达并纯化的猪伪狂犬病病毒gB重组蛋白作为包被抗原,以辣根过氧化物酶标记的抗gB蛋白单克隆抗体作为酶标抗体,以国家参考品稀释制备的校准品绘制标准曲线实现定量检测,成功建立的PRV-gB-CLEIA在45 min内即可完成检测,可检测到最大稀释倍数为1：2 048稀释的国家参考品;与猪瘟等其他5种病毒抗原的标准阳性血清无交叉反应;批内变异系数为1.13%~9.47%,批间变异系数为2.43%~14.07%,重复性和稳定性较好。通过对采集的180份临床血清检测结果进行比较,该方法与中和试验阳性符合率为94.00%,阴性符合率为96.92%,总符合率为96.11%,明显优于商品化ELISA试剂盒。本研究建立的PRV-gB-CLEIA检测方法可以用于PRV gB抗体的快速定量检测。     

某规模化猪场猪伪狂犬gE和gB抗体的检测与分析

[目的]了解龙岩市某规模化猪场猪伪狂犬野毒感染状况和免疫抗体水平。[方法]采用ELISA法对2010~2013年该场采集的种猪和育肥猪群的血清样品共1 217份进行猪伪狂犬野毒(gE)抗体和免疫(gB)抗体检测。[结果]种猪与育肥猪猪伪狂犬野毒总样品阳性率分别为13.5%和28.4%,其中60~100日龄的育肥猪总样品阳性率为5.2%,100~210日龄的总样品阳性率为42.1%;种猪伪狂犬免疫抗体总样品阳性率分别为92.2%,60~160日龄的育肥猪猪伪狂犬免疫抗体阳性率呈波动变化,血清样品总阳性率为50%。[结论]该猪场育肥猪群野毒感染率较种猪群高,且100日龄以后的育肥猪群野毒感染率较高,种猪群的免疫抗体水平高于育肥猪群,80~130日龄育肥猪免疫抗体水平较低。     

闽北地区猪伪狂犬病抗体检测分析

为了解猪伪狂犬病在闽北地区的流行情况,整理并分析2015年度血清抗体检测数据。采用ELISA检测方法对闽北地区45个规模化猪场进行检测分析,通过检测样品血清中伪狂犬病gE抗体和gB抗体的水平进行结果判定。结果显示：送检的45个规模化猪场,伪狂犬病gE抗体阳性场达25个,猪场阳性率达55.6%;共检测1304份血清,其中伪狂犬病gE抗体阳性213份、可疑24份、阴性1067份,抗体阳性率达20.6%。从伪狂犬病gE抗体阴性猪场抽检猪伪狂犬gB抗体380份,gB抗体阳性258份,猪群伪狂犬病抗体保护率仅有67.9%。     

3种猪伪狂犬病gB抗体ELISA检测试剂盒的比较

采用3种猪伪狂犬病gB抗体ELISA检测试剂盒检测121份血清样品,对检测结果进行Kappa一致性检验。结果显示:3种gB抗体检测试剂盒都具有很好的重复性,两两之间检测结果的符合率达80%以上,Kappa值0.6,表明3种检测试剂盒具有较好的重复性和一致性。     

表达鸡马立克氏病病毒gB基因重组鸡痘病毒的遗传稳定性及生物安全性评价

为了评价表达鸡马立克氏病病毒gB基因重组鸡痘病毒(rFPV-gB/R)的遗传稳定性,我们将纯化后的重组病毒在CEF单层上连续传30代,引起细胞病变的速度和形态均未发生明显变化;覆盖含X-Gal的琼脂引起的空斑均为蓝色;间接免疫荧光实验证明rFPV-gB/R中的gB基因始终能稳定表达;序列测定结果表明,重组病毒在细胞上连续传30代、在SPF鸡上连续传5代后,gB基因序列没有发生任何变化;以0、10、20、30代重组病毒制成冻干疫苗进行的实验室免疫效力实验表明,细胞连续传代后rFPV-gB/R仍然保持了原有的免疫原性。可见重组鸡痘病毒gB基因的结构和免疫原性都是高度稳定的。为了评价rFPV-gB/R的生物安全性,我们将rFPV-gB/R通过SPF鸡连续传5代,检测病毒在鸡体的存在部位及其消长、生长繁殖性能和毒力变化;将rFPV-gB/R免疫鸡与未免疫鸡同笼饲养,攻击FPV-102E6强毒,以检测rFPV-gB/R感染鸡的接触传染性。结果显示,rFPV-gB/R在鸡体的存在时间大约为7d,在体内仅存在于接种部位;鸡体传代后痘病毒毒力有一定程度下降,gB基因核苷酸序列未发生任何变化;同居未免疫SPF鸡在痘病毒强毒攻击后全部发痘,可见重组病毒免疫鸡没有接触传染性,能在鸡体内稳定地传代,rFPV-gB/R具有高度的生物安全性。     

Bovine herpesvirus 4-associated postpartum metritis in a Spanish dairy herd

In more than 10 Spanish dairy cows, a bovine herpesvirus 4 (BHV4) associated postpartum metritis was confirmed by virus isolation, BHV4-glycoprotein B (gB) PCR and/or serology. In this study, 12 cows with, and, at the time of sampling, 3 cows without clinical signs of acute postpartum metritis from one large dairy herd in Spain were examined for bacterial and viral infections. Blood, placenta/caruncles and uterine contents were collected between day 1 and day 20 post-calving, and examined for the presence of bacteria and for viruses by virus isolation, BHV4 DNA by BHV4-gB PCR and/or BHV4 antibody titres. Bovine herpesvirus 4 was detected in 83% of the cases with clinical signs of acute postpartum metritis by virus isolation and/or BHV4-gB PCR. An increase of BHV4 antibodies was detected in all examined postpartum metritis cows and in the 3 cows without clinical metritis. Two of these 3 cows developed severe metritis a few dayss after collecting the first blood sample. A concurrent infections of BHV4 and bacteria, mainly Arcanobacterium pyogenes and Streptococcus sp., were detected in 73% of the examined uterine contents collected from postpartum metritis affected cows. This case-report study showed a clear association between BHV4 infections and acute postpartum metritis in dairy cows. In addition, the BHV4-associated postpartum metritis appeared to be an emerging syndrome in this Spanish herd.     

抗鸡传染性喉气管炎重组鸡痘病毒基因工程疫苗同居感染试验

疫苗的接触传播是疫苗免疫接种需要考虑的重要因素,为了检测重组鸡痘病毒载体疫苗水平传播的能力,对隔离条件下饲养的SPF鸡用重组鸡痘病毒基因工程疫苗接种,同时设立非免疫对照鸡,饲养期间特意延长清粪时间以增加感染的机会,1个月之后攻击传染性喉气管炎WG株强毒和鸡痘102株强毒,疫苗免疫鸡全部获得保护,而非免疫鸡则全部发病.在试验动物饲养场的自然条件下,将免疫鸡和试验对照两组鸡饲养在同一个鸡舍内,让疫苗毒的传播更接近自然条件.在每个月的攻毒试验中,对照鸡都没有获得对鸡痘和传染性喉气管炎强毒的保护.在疫苗免疫期间进行连续5个月的跟踪检测,同居未免疫鸡没有检测到抗传染性喉气管炎病毒gB抗体.这些实验结果表明抗鸡传染性喉气管炎重组鸡痘病毒基因工程疫苗不能通过接触传播.